Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Characterization of pandemic influenza immune memory signature after vaccination or infection.

Bonduelle O, Carrat F, Luyt CE, Leport C, Mosnier A, Benhabiles N, Krivine A, Rozenberg F, Yahia N, Samri A, Rousset D, van der Werf S, Autran B, Combadiere B.

J Clin Invest. 2014 Jul;124(7):3129-36. doi: 10.1172/JCI74565. Epub 2014 Jun 9.

2.

Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination.

Bonduelle O, Yahia N, Siberil S, Benhabiles N, Carrat F, Krivine A, Rozenberg F, Dimitrov J, Kaveri SV, Curjol A, Tindel M, Louet M, Desert F, Launay O, Loulergue P, Badre G, Katlama C, Bricaire F, Samri A, Rousset D, van der Werf S, Jauréguiberry S, Combadiere B.

J Immunol. 2013 Jul 15;191(2):623-31. doi: 10.4049/jimmunol.1203483. Epub 2013 Jun 17.

3.

Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination.

Wagar LE, Rosella L, Crowcroft N, Lowcock B, Drohomyrecky PC, Foisy J, Gubbay J, Rebbapragada A, Winter AL, Achonu C, Ward BJ, Watts TH.

PLoS One. 2011;6(11):e28063. doi: 10.1371/journal.pone.0028063. Epub 2011 Nov 23.

4.

CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.

Schmidt T, Dirks J, Enders M, Gärtner BC, Uhlmann-Schiffler H, Sester U, Sester M.

Eur J Immunol. 2012 Jul;42(7):1755-66. doi: 10.1002/eji.201242393.

5.

Long-term persistence of humoral and cellular immune responses induced by an AS03A-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized study in adults aged 18-60 years and older.

Van Damme P, Kafeja F, Bambure V, Hanon E, Moris P, Roman F, Gillard P.

Hum Vaccin Immunother. 2013 Jul;9(7):1512-22. doi: 10.4161/hv.24504. Epub 2013 Apr 9.

PMID:
23571166
6.

Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals.

Chawansuntati K, Chotirosniramit N, Sugandhavesa P, Aurpibul L, Thetket S, Kosashunhanan N, Supindham T, Kaewthip O, Sroysuwan P, Sirisanthana T, Suparatpinyo K, Wipasa J.

Hum Vaccin Immunother. 2015;11(9):2253-65. doi: 10.1080/21645515.2015.1051275. Epub 2015 Jun 19.

7.

Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees.

Herrera MT, Gonzalez Y, Juárez E, Hernández-Sánchez F, Carranza C, Sarabia C, Guzman-Beltran S, Manjarrez ME, Muñoz-Torrico M, Garcia-Garcia L, Sada E, Torres M.

BMC Infect Dis. 2013 Nov 15;13:544. doi: 10.1186/1471-2334-13-544.

8.

Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.

Hsu JP, Phoon MC, Koh GC, Chen MI, Lee VJ, Wu Y, Xie ML, Cheong A, Leo YS, Chow VT.

Int J Infect Dis. 2012 Aug;16(8):e621-7. doi: 10.1016/j.ijid.2012.04.010. Epub 2012 Jun 15.

9.

Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic.

Magalhaes I, Eriksson M, Linde C, Muhammad R, Rane L, Ambati A, Axelsson-Robertson R, Khalaj B, Alvarez-Corrales N, Lapini G, Montomoli E, Linde A, Pedersen NL, Maeurer M.

BMC Infect Dis. 2014 Jun 11;14:319. doi: 10.1186/1471-2334-14-319.

10.

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.

Crowe BA, Brühl P, Gerencer M, Schwendinger MG, Pilz A, Kistner O, Koelling-Schlebusch K, Aichinger G, Singer J, Zeitlinger M, Müller M, Ehrlich H, Barrett PN.

Vaccine. 2010 Dec 16;29(2):166-73. doi: 10.1016/j.vaccine.2010.10.065. Epub 2010 Nov 4.

PMID:
21055500
11.

Longevity and determinants of protective humoral immunity after pandemic influenza infection.

Sridhar S, Begom S, Hoschler K, Bermingham A, Adamson W, Carman W, Riley S, Lalvani A.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):325-32. doi: 10.1164/rccm.201410-1798OC.

12.

One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies.

Faenzi E, Zedda L, Bardelli M, Spensieri F, Borgogni E, Volpini G, Buricchi F, Pasini FL, Capecchi PL, Montanaro F, Belli R, Lattanzi M, Piccirella S, Montomoli E, Ahmed SS, Rappuoli R, Del Giudice G, Finco O, Castellino F, Galli G.

Vaccine. 2012 Jun 8;30(27):4086-94. doi: 10.1016/j.vaccine.2012.04.020. Epub 2012 Apr 19.

PMID:
22521851
13.

Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.

Strengell M, Ikonen N, Ziegler T, Kantele A, Anttila VJ, Julkunen I.

Influenza Other Respir Viruses. 2013 May;7(3):431-8. doi: 10.1111/j.1750-2659.2012.00415.x. Epub 2012 Aug 23.

14.

[Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes].

Naĭkhin AN, Koren'kov DA, Chirkova TV, Petukhova GD, Donina SA, Rudenko LG.

Vopr Virusol. 2011 Sep-Oct;56(5):15-21. Russian.

PMID:
22171472
15.

A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.

Hessel A, Schwendinger M, Fritz D, Coulibaly S, Holzer GW, Sabarth N, Kistner O, Wodal W, Kerschbaum A, Savidis-Dacho H, Crowe BA, Kreil TR, Barrett PN, Falkner FG.

PLoS One. 2010 Aug 16;5(8):e12217. doi: 10.1371/journal.pone.0012217.

16.

Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients.

Baluch A, Humar A, Egli A, Gubbay J, Lisboa L, Wilson L, Kumar D.

PLoS One. 2011;6(12):e28627. doi: 10.1371/journal.pone.0028627. Epub 2011 Dec 14.

17.

Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs.

Loving CL, Vincent AL, Pena L, Perez DR.

Vaccine. 2012 Aug 31;30(40):5830-8. doi: 10.1016/j.vaccine.2012.07.033. Epub 2012 Jul 24.

18.

Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.

Chirkova TV, Naykhin AN, Petukhova GD, Korenkov DA, Donina SA, Mironov AN, Rudenko LG.

Clin Vaccine Immunol. 2011 Oct;18(10):1710-8. doi: 10.1128/CVI.05116-11. Epub 2011 Aug 3.

19.

Keeping the memory of influenza viruses.

Combadière B, Sibéril S, Duffy D.

Pathol Biol (Paris). 2010 Apr;58(2):e79-86. doi: 10.1016/j.patbio.2010.01.010. Epub 2010 Mar 19. Review.

PMID:
20303671
20.

Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.

Liu W, Ma MJ, Tang F, He C, Zhang XA, Jiang LF, Xin DS, Hu CY, Looman C, Cao WC.

Vaccine. 2012 Jul 6;30(32):4785-9. doi: 10.1016/j.vaccine.2012.05.030. Epub 2012 May 24.

PMID:
22633868

Supplemental Content

Support Center